GAO Guang-ping,VANDENBERGHE L H,ALVIRA M R,et al.Clades of adeno-associated viruses are widely disseminated in human tissues[J].J Virol,2004,78(12):6381-6388.
QI Yan-fei,LIU Xuan,LI Hong-wei,et al.Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue[J].J Gene Med,2010,12(1):22-34.
[4]
LIMBERIS M P,WILSON J M,Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered[J].Proc Natl Acad Sci USA,2006,103(44):12993-12998.
[5]
MIAO R Q,AGATA J,CHAO L,et al.Kallistatin is a new inhibitor of angiogenesis and tumor growth[J].Blood,2002,100(9):3245-3252.
[6]
TSE Lai-yin,SUN Xue-ying,JIANG Hong-chi,et al.Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas[J].J Gene Med,2008,10(5):508-517.
[7]
XU R,RAHIMI M,MA H,et al.Stability of infectious recombinant adeno-associated viral vector in gene delivery[J].Med Sci Monit,2005,11(9):R305-R308.
[8]
GRIEGER J C,CHOI V W,SAMULSKI R J,Production and characterization of adeno-associated viral vectors[J].Nat Protoc,2006,1(3):1412-1428.
[9]
MITCHELL M,NAM H J,CARTER A,et al.Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9[J].Acta Crystallogr F,2009,65:715-718.
[10]
BOUTIN S,MONTEILHET V,VERON P,et al.Prevalence of serum IgG and neutralizing factors against adeno-associated virus(AAV)types 1,2,5,6,8, and 9 in the healthy population: Implications for gene therapy using AAV vectors[J].Hum Gene Ther,2010,21(6):704-712.
[11]
DIAO Yong,MA Jun,XIAO Wei-dong,et al.Inhibition of angiogenesis and Hg-116 xenograft tumor growth in mice by kallistatin[J].World J of Gastroenterol,2007,13(34):4615-4619.
[12]
JRMSL A,BTSY F,CENTER M M,et al.Global cancer statistics[J].Cancer J Clin,2011,61(2):69-90.
[13]
XU Rui-an,SUN Xue-ying,TSE Lai-yin,et al.Long-term expression of angiostatin suppresses metastatic liver cancer in mice[J].Hepatology,2003,37(6):1451-1460.
MAGUIRE A M,SIMONELLI F,PIERCE E A, et al.Safety and efficacy of gene transfer for Leber’s congenital amaurosis[J].N Engl J Med,2008,358(21):2240-2248.
